title: Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis.
authors: Department of Internal Medicine1 Department of Clinical Pharmacy and Toxicology2 Martini Hospital Unit of PharmacoEpidemiology and PharmacoEconomics3 Department of Pharmacy University of Groningen Department of Clinical Microbiology4 Martini Hospital Groningen, Netherlands.
authors: P J
authors: PJ
authors: Vlaar
authors: M
authors: M
authors: van Hulst
authors: C A
authors: CA
authors: Benne
authors: W M
authors: WM
authors: Janssen
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D019540:Area Under Curve; D003928:Diabetic Nephropathies / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D000077731:Meropenem; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D013845:Thienamycins / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem